The growth of Viagra and its effect on the drug landscape presents a complicated question for traders. While the early sales data were remarkable, the patent has ended, leading to a wave of off-brand alternatives that are eroding revenue. In addition, the industry is facing challenges related to demographic trends and changing healthcare regulation